Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity

Fungi cause disease in nearly one billion individuals worldwide. Only three classes of antifungal agents are currently available in mainstream clinical use. Emerging and drug-resistant fungi, toxicity, and drug-drug interactions compromise their efficacy and applicability. Consequently, new and impr...

Descripción completa

Detalles Bibliográficos
Autores principales: Duncan, Vanessa, Smith, Daniel, Simpson, Laura, Lovie, Emma, Katvars, Laura, Berge, Leon, Robertson, Jennifer, Smith, Shane, Munro, Carol, Mercer, Derry, O’Neil, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284473/
https://www.ncbi.nlm.nih.gov/pubmed/34031048
http://dx.doi.org/10.1128/AAC.02345-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284473/
https://www.ncbi.nlm.nih.gov/pubmed/34031048
http://dx.doi.org/10.1128/AAC.02345-20

Ejemplares similares